MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Income Overview

Revenue
$9,633K
Net Income
-$4,417K
Net Profit Margin
-45.85%
EPS
-$0.07
Unit: Thousand (K) dollars
Revenue Breakdown
    • All Other Countries
    • DE
    • US
Revenue Breakdown
    • Sales Channel Directly To Consum...
    • Sales Channel Through Intermedia...
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue, net
9,633
8,864
9,233.762
9,485
Cost of goods sold
2,584
2,734
2,430.359
2,819
Gross profit
7,049
6,130
6,803.403
6,666
Research and development, net of grant income
1,453
1,025
1,242.075
918
Selling, general and administrative
7,964
8,149
9,436.12
8,610
Restructuring
270
-
510
-
Total operating expenses
9,687
9,174
11,188.195
9,528
Loss from operations
-2,638
-3,044
-4,384.792
-2,862
Interest expense, net
-868
-857
-745.866
-645
Gain (loss) on foreign currency transactions
-911
-1,228
193.016
-64
Loss on abandoned patents
-
-
559
-
Total other income (expense), net
-1,779
-2,085
-1,111.85
-709
Loss before benefit from income taxes
-
-
-4,695*
-3,571
Benefit from income taxes
-
-
802*
-401
Net income (loss)
-4,417
-5,129
-5,496.642
-3,170
Basic EPS
-0.07
-0.08
-0.087
-0.05
Diluted EPS
-0.07
-0.08
-0.094
-0.05
Basic Average Shares
62,806,694
62,738,827
62,832,598
62,753,959
Diluted Average Shares
62,806,694
62,738,827
58,274,819
62,753,959
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

CTSO Income Statement Sankey DiagramSankey diagram visualizing CTSO income statement for the periodSales Channel ThroughIntermediary$4,619K Sales ChannelDirectly To Consumer$2,273K Revenue From ContractWith Customer...$2,541K Revenue From ContractWith Customer...$200K All Other Countries$6,892K DE$2,541K US$200K Net income (loss)-$4,417K (-326.86%↓ Y/Y)Revenue, net$9,633K (0.17%↑ Y/Y)Loss from operations-$2,638K (27.03%↑ Y/Y)Total other income(expense), net-$1,779K (-131.98%↓ Y/Y)Gross profit$7,049K (3.45%↑ Y/Y)Cost of goods sold$2,584K (-7.81%↓ Y/Y)Total operatingexpenses$9,687K (-7.11%↓ Y/Y)Gain (loss) onforeign currency...-$911K (-114.75%↓ Y/Y)Interest expense, net-$868K (-40.91%↓ Y/Y)Selling, general andadministrative$7,964K (-13.12%↓ Y/Y)Research anddevelopment, net of grant...$1,453K (15.13%↑ Y/Y)Restructuring$270K

Cytosorbents Corp (CTSO)

Cytosorbents Corp (CTSO)